Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM
ConclusionThe current data provide evidence that oxLDL, its retroactive enzyme and antibody are present in circulation early in childhood when primed by obesity and hyperglycemia in T1DM and suggests that they could be useful markers for cardiovascular diseases (CVD).
Source: Bulletin of Faculty of Pharmacy, Cairo University - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 1 | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Heart | Insulin | Obesity | Study